• Latest Posts

GammaDelta Therapeutics Spins Out Cancer Immunotherapy Biotech

In Depth 11 Jun 2019

Gamma Delta T Cells: A New Hope Against Cancer

Abingworth Closes €268M to Invest in Life Science Companies

Interview 24 Jul 2017

Discussing Open Science with the Head of Translation at The Francis Crick Institute

Interview 12 Jun 2017

This Italian Academic-turned-CEO also Launched 7 Cancer Drugs at GSK

More News! 9 May 2017

British Biotech Startup Partners with Takeda to Advance its T Cell Platform

Abingworth launches UK Immuno-Oncology Startup with Seed Funding